SAN FRANCISCO, Sept. 1, 2026 – Tripo AI, the world’s leading AI company in generative 3D, has raised approximately 3 billion yuan in its Series B and Series B+ financing rounds as the company announced a major breakthrough in AI 3D generation.
Tripo P2.0
Led by MPCi, the latest funding attracted a diverse set of institutions from various sectors. Major strategic and industry investors included Perfect World, BlueFocus, SPC, Yanqu Games, ThunderSoft, and 37 Interactive Entertainment. The financing rounds were also backed by financial investors such as CDH Venture and Growth Capital, CICC, CMC Capital Partners, Hongtai Aplus, 3H Health, Zhongping Capital, and GreatOrigin Asia. Existing investors Fortune Capital, Primavera Capital, 4399 Network, Muhua Tech Ventures, Vitalbridge Capital, INCE Capital, and T-Capital further increased their investments.
The completion of the financing rounds came as Tripo announced a major breakthrough in 3D-native foundation models with the preview release of Tripo P2.0, its latest 3D-native foundation model that allows quad topology, a first for the industry. As an upgrade from Tripo P1.0, P2.0 enables the generation of high-quality and production-ready 3D objects in mere seconds.
Enterprises across industries have deployed Tripo’s 3D-native foundation models as the company continues to push the boundaries of what AI 3D technology can achieve. The latest financing rounds reinforce the leading status of Tripo AI in generative 3D.
The funding will accelerate the development and advancement of 3D-native foundation models and 3D data infrastructure, expand computing infrastructure for AI training and inference, and fuel product development and commercialization.
About Tripo AI
Tripo AI is a global leader in the development of 3D-native foundation models and world models. Founded in 2023 by leading scientists in AI and computer graphics, the company has developed a comprehensive end-to-end product ecosystem, built around its proprietary 3D-native foundation models and world models. With Tripo Studio and Tripo API, Tripo AI has transformed 3D generation. Powered by a world-class AI 3D research team, the company is advancing AI toward understanding, generating, and interacting with 3D environments.
Tripo AI’s models and products have been widely adopted by individual users and enterprises globally, serving industries including intelligent manufacturing, virtual reality, interactive entertainment, and embodied AI, empowering enterprises to unlock new productivity and scale applications of generative 3D.
Financing led by The Venture City, Capital Factory, Scalpel Ventures and Evoce Capital; funds will be utilized to run multiple clinical studies in oncology to advance a novel and revolutionary red blood cell based liquid biopsy platform invented at the University of Pennsylvania.
PHILADELPHIA, Sept. 1, 2026 — Senticell, Inc. (“Senticell” or the “Company”), a biotechnology company pioneering a new class of liquid biopsy built on red blood cell (RBC)-bound nucleic acids, today announced the closing of an oversubscribed seed financing round approaching $7 million. The round drew participation from The Venture City, Capital Factory, Scalpel Ventures, Evoce Capital, as well as a group of high-net-worth individuals.
“This financing reflects strong investor conviction in the underlying science and in our team’s ability to translate that science into a scalable diagnostic platform,” said Neha Shah, Co-founder and Chief Executive Officer of Senticell. “Being oversubscribed and welcoming a group of investors who understand the clinical need firsthand, gives us both the capital and the opportunity to rapidly advance what will be a major breakthrough in cancer diagnosis and ultimately treatment decision-making.”
Senticell’s liquid biopsy platform is exclusively licensed to the company from the University of Pennsylvania and is built on more than a decade of published, peer-reviewed research demonstrating red blood cells actively bind and retain disease-associated DNA and RNA. These unique insights were first identified by Dr. Nilam Mangalmurti, who is the scientific co-founder of Senticell and acts as the company’s Chief Scientific Advisor.
Since red blood cells are the body’s most abundant cell type (an estimated 30 trillion in circulation), remain in circulation for roughly 120 days, and come into contact with every tissue in the body, they represent a largely untapped molecular diagnostic reservoir that can significantly lower limits of detection of liquid biopsy. Senticell is rapidly advancing a proprietary RBC liquid biopsy platform to identify clinically actionable disease signals in oncology that today’s plasma-based tests miss and enable more consistent application in early-stage disease and low-shedding tumor states.
“Decades of research suggested that red blood cells were doing far more than carrying oxygen. Our discovery that red blood cells bind nucleic acids revealed that they could provide a distinct window into disease—one that may capture information not readily accessible through conventional liquid biopsies. Importantly, we recognized that this biology could be harnessed for diagnostics. That insight led to the development of a new technology to isolate and rapidly analyze RBC-associated nucleic acids, including oncogenic driver mutations. We are now building on this discovery to develop a reliable diagnostic platform with the potential to transform cancer detection and improve patient lives,” said Dr. Mangalmurti.
Central to Senticell’s data package are two prospective clinical studies currently underway at Penn Medicine, together enrolling approximately 300 patients and comparing Senticell’s red-cell signal against plasma-based tests and determining tissue concordance. The company is actively enrolling 200 lung and pancreatic cancer patients at UPenn, evaluating pre-surgical driver detection and recurrence monitoring, with completion in Q1 2027. In addition, Senticell is providing RBC-based in-vitro analytical support for a clinical study (head & neck and cervical cancer cohorts, ~100 patients across UPenn and UPenn-Botswana) evaluating MRD and post-treatment monitoring, with results expected in Q4 2026. Finally, foundational work under Senticell’s Sponsored Research Agreement with Penn Medicine is establishing rapid, culture-independent pathogen detection for sepsis and pneumonia on the RBC platform; the Company expects to formalize this into a dedicated clinical study following the completion of its oncology proof-of-concept work.
With its transformative technology based on decades of research, Senticell has attracted a world-class scientific advisory board including:
Steven Albelda, MD (Penn Medicine, Emeritus), a tumor immunologist and co-founder of Capstan Therapeutics (acquired by AbbVie)
Chris Hunter, PhD (Penn Vet), a cytokine biologist and founder of Surface Oncology (acquired by Coherus)
David Roth, MD, PhD (Penn Medicine, Emeritus), founder of the Center for Personalized Diagnostics at UPenn.
“I have closely followed Dr. Mangalmurti’s research at Penn. Senticell will translate these basic science findings into clinically applicable RBC-platforms that will be more sensitive, more rapid, and less expensive than currently available testing approaches in diseases like cancer and infections,” said Dr. Steven Albelda, Scientific Advisor to Senticell.
Looking ahead, Senticell views this seed round as the foundation for a much broader platform. “Red blood cells have been hiding in plain sight as a diagnostic tool for decades, and we are just beginning to unlock what they can tell us,” said Shah. “Our vision is to build the definitive RBC-based diagnostics platform, one that starts in oncology but ultimately extends across disease areas where earlier, more sensitive detection can change how patients are treated. This is the first step toward making that a reality.”
About Senticell
Senticell is a biotechnology company developing a new class of liquid biopsy diagnostics based on red blood cell (RBC)-bound nucleic acids. Founded on research pioneered at Penn Medicine, Senticell’s platform is designed to unlock disease signals that plasma-based liquid biopsy often cannot detect, with initial applications in oncology and infectious diseases. Senticell holds an exclusive, worldwide license to its foundational RBC platform from the University of Pennsylvania and is based in Philadelphia, Pennsylvania. For more information, visit www.senticell.bio.
Initial Hot-Fire Testing Successfully Demonstrated the Next-Generation Drop-In Rocket Propellant in Venus’ Rotating Detonation Rocket Engine
SALT LAKE CITY and HOUSTON, Sept. 1, 2026 — Today, CycloKinetics, Inc. announced that it has selected Venus Aerospace and its rotating detonation rocket engine (RDRE) technology to test CycloRP fuel, a drop-in replacement for RP-1/RP-2. CycloKinetics, which produces drop-in propellants designed to work in existing engines without modification, has designed CycloRP, built for higher energy density and cleaner combustion, as a replacement for RP-1 and RP-2. The testing program is sponsored by the United States Air Force Research Laboratory and backed by the Department of War’s Office of the Under Secretary of War for Research and Engineering.
Testing will happen in two rounds. The first, completed in July 2026, evaluated CycloRP’s combustion performance in the RDRE and confirmed the fuel detonates successfully. The second will build on those results to assess CycloRP’s performance as a coolant, circulating the fuel through the engine to help manage temperature, measured against the known cooling performance of RP-1/RP-2. Results from both rounds will feed into a fuller technical readout expected in early 2027.
“We built CycloRP to be a true drop-in replacement, no engine redesign, no compromise on performance, and testing it in a live rotating detonation rocket engine, backed by the U.S. Air Force, is exactly the kind of real-world validation this technology needs,” said Mukund Karanjikar, CEO and founder of CycloKinetics. “Our work with Venus Aerospace serves as a strong example of how domestically produced propellants can support the next generation of hardware, manufactured right here in the U.S.”
“Our flight-proven rotating detonation rocket engine is changing what’s possible in propulsion. Efficient fuel is a critical piece of getting there,” said Sassie Duggleby, Co-Founder and CEO of Venus Aerospace. “This testing gives the Air Force and CycloKinetics the chance to see how a domestically produced, drop-in propellant performs in real hot-fire testing, side by side with the fuels we know today. Testing like this is how we get to a different economics of space.”
This testing builds upon previous testing CycloKinetics and Venus conducted in June 2025 at Venus’ Houston facility. This new program builds on that work and reflects continued momentum for both companies.
Both companies plan to share updates once final testing has concluded.
About CycloKinetics CycloKinetics, headquartered in Salt Lake City, Utah, is an advanced technology company developing high-performance, fully drop-in propellants and fuels for aerospace and defense applications. Its proprietary propellants are designed to outperform conventional propellants and fuels while integrating seamlessly into existing systems, enabling improved range, endurance, payload capacity, and overall mission performance. Its propellants are drop-in replacements for the current propellants and fuels which power turbine-powered platforms including Unmanned Aircraft Systems (UAS) for Counter-Unmanned Aircraft Systems (C-UAS) and Collaborative Combat Aircraft (CCA) applications, long-range and attritable missiles, next-generation propulsion, space launch systems, and commercial jets.
CycloKinetics produces its propellants domestically, supporting secure and rapidly scalable supply for defense and aerospace customers. Its industrial manufacturing facility in Salt Lake City became operational in 2025, with deliveries to customers already underway. The company’s feedstock-flexible production process enables manufacturing to be optimized for locally available resources, strengthening supply chain resilience and supporting distributed and in-theater production capabilities. For more information, visit www.cyclokinetics.com
About Venus Aerospace Venus Aerospace is building next-generation propulsion systems for defense, space, and future high-speed flight. Founded in 2020 and headquartered in Houston, Texas, Venus is developing flight-proven Rotating Detonation Rocket Engine (RDRE) technology designed to deliver greater efficiency, range, and scalability for defense and space missions. Venus’ propulsion systems are designed for domestic manufacturing and mission flexibility across national security and aerospace applications. Venus is backed by Mercury Fund, Lockheed Martin Ventures, Prime Movers Lab, Airbus Ventures, Trousdale Ventures and others. To learn more, visit www.venusaero.com.
Led by Insight Partners with participation from Galvanize, the round will accelerate US expansion of Gridsight’s AI-driven capacity management solutions amid the strongest sustained growth in electricity demand in decades.
SAN FRANCISCO, Sept. 1, 2026 — Gridsight, the AI-powered capacity management platform for utilities, today announced it has raised a US$26 million Series B led by Insight Partners, with participation from Galvanize and existing investors Airtree, Energy Transition Ventures and Aera VC. The round will accelerate Gridsight’s US expansion while supporting continued growth in Australia at a moment when utilities face their most complex capacity challenge in decades, connecting a surge of data centers, EVs and distributed energy resources while keeping power affordable and reliable for the customers and communities they serve.
US electricity demand is rising after fifteen years of stagnant growth, driven by AI data centers, EVs, and electrification. But new construction alone cannot meet this growing demand. As the cost and timeline of building new infrastructure climb, regulators are shifting incentives toward better use of existing grid capacity. The opportunity lies within existing networks, where as much as three-quarters of grid capacity goes unused on average, varying by location, time of day, and season. Greater visibility and smarter management of this latent capacity allows utilities to connect more load today, without waiting for new infrastructure. Gridsight’s intelligent platform gives utilities a unified view of available network capacity and the tools to act on it in real-time.
“The grid’s capacity challenge is not uniform,” said Brendan Banfield, Co-founder and CEO of Gridsight. “For the majority of the year, significant capacity exists; but it is uneven, dynamic and geographically dependent. Our platform helps utilities quantify that capacity, connect customers faster and direct investment to the pockets of the grid that maximize its impact. Our goal at Gridsight is to use data and intelligence to ensure energy is an enabler for economic and technological progress, not its limiting factor.”
Gridsight is already working with leading US utilities, including Xcel Energy and United Illuminating, an Avangrid subsidiary. In Australia, where Gridsight was founded, Endeavour Energy deployed Gridsight’s unified capacity management platform for real-time solar management, doubling static solar export capacity for households from 5 kW to 10 kW paired with real-time dynamic control to protect the local grid. This program is expected to unlock more than $100 million in value for customers and 600 MW of additional solar capacity for the grid.
“Australia leads the world in rooftop solar adoption, and Endeavour Energy is at the forefront of that transition. Gridsight has been an invaluable strategic partner since 2021, helping us embrace AI and make data-led decisions on how we connect, manage, flex and plan our network. We’ve doubled customers’ solar export capacity within our existing poles and wires, are operating the grid closer to its full potential, and delivering better value for our customers. We’re proud of our partnership with Gridsight and the work we’re doing to accelerate Australia’s energy transition.” said Danny Cooper, CEO Endeavour Energy.
At the core of Gridsight’s platform is its Foundational Grid Model, a continuously updated, utility-specific model that brings fragmented grid data into a single, trusted view of the network. Unlike general-purpose AI, Gridsight’s AI agents combine utility-specific grid models with electrical physics to help engineers analyze complex networks in real-time, make better, faster decisions, and drive automation.
“Gridsight is now an integral part of how our Distribution teams operate and plan, turning data our network produces into intelligence our engineers can act on. As complexity in our distribution system continues to grow, this partnership helps us make rapid decisions to safely get the most out of our existing grid.” – Todd Conner, Senior Vice President, Electric Distribution Xcel Energy
With deployments at leading utilities across the US and Australia, Gridsight is translating platform capability into measurable outcomes at scale. This round of US expansion comes as demand growth accelerates and grid investment cycles lengthen, meaning utilities are increasingly looking for solutions that deliver results within existing infrastructure. This is the problem Gridsight was built to solve.
“The energy transition is stress-testing utility networks in ways they were never designed to handle,” said Rachel Geller, Managing Director at Insight Partners, “Gridsight’s platform provides the intelligence, visibility, and control needed to unlock latent capacity, connect more load, and stay ahead of demand without waiting for new infrastructure. The US market opportunity is substantial, and we’re proud to back this team.”
About Gridsight
Gridsight is the AI-powered capacity management platform for utilities. Founded in Sydney, Australia in 2020, Gridsight gives utilities a dynamic, decision-ready view of what their networks can carry, where and when, helping them connect new demand faster, make better use of existing infrastructure and direct investment where it is needed most. Its customers span Australia, New Zealand, the United States, and the UK. More at gridsight.ai.
About Insight Partners
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing tailored, hands-on software expertise throughout their growth journey, from first investment to IPO.
About Galvanize
Galvanize is a global asset manager investing at the intersection of energy innovation, resilience, and intelligence. The firm deploys capital across seed, venture, growth, public equities, credit, and real estate, combining investment expertise with deep in-house capabilities in technology, policy, and markets. Galvanize is structured to rapidly identify and execute on investment opportunities created by the energy transition, across all sectors of the economy.
Orbis streams interactive 4K video at 24 frames per second, responds to user intervention instantly, and sustains hour-scale generation without evident visual or color drift.
SUNNYVALE, Calif., Sept. 1, 2026 — Visko, the AI research company behind Live Models, today announced a $10 million pre-seed round of fundraising and opened public access to Orbis — the foundation model that creates living worlds and streams them in real time, with persistent memory, interactivity, and physics-grounded generation of unbounded length.
Overview of Visko Orbis 1.0 as a real-time, interactive long-video generation system. (Provided by Visko)
Top: Quality, alignment, and motion measurements on one- to three-minute event-based benchmark. Bottom: Overall long-form video Arena point estimates from the human preference study. VISKO Orbis 1.0 obtains the highest overall score; The table provides the dimension-level comparison and citations for all baselines. (Provided by Visko)
Most AI video generators work offline: a user submits a prompt, waits, and receives a finished clip that cannot be changed. Visko’s models belong to a class the company calls Live Models — models that run rather than render. Orbis generates video continuously and in real time. Users can change the prompt at any moment during generation and see the update reflected instantly while the video keeps streaming.
According to the company’s technical report, Orbis delivers 4K video at 24 frames per second in real time and sustains hour-scale generation without evident quality or color drift. Generation is grounded in physical dynamics: a latent world model scores candidate futures during inference, steering output toward physically plausible motion and object dynamics.
In the report’s evaluations, Orbis leads compared real-time and long-video systems on DOVER aesthetic and technical quality and on VideoAlign visual and motion quality, and records the highest overall-preference and temporal-stability ratings in the report’s long-form human preference study across eight systems. The report also discloses dimensions where Orbis trails other systems, with full methodology and results published.
“Every real-time system before this faced the same wall: the longer a world runs, the more it falls apart. We built Orbis to hold together — physically, visually and narratively — for as long as you want to stay inside it. Starting today, anyone can see that for themselves at visko.ai,” said Qing (Will) Yin, founder and chief executive officer of Visko.
Dr. Michael I. Jordan from UC Berkeley, the Chairman of the Advisory Board of Visko, comments, “Visko is pursuing one of the most ambitious directions in video AI: live, stateful models that continuously perceive, predict, and interact with the world in real time while maintaining physical consistency. Visko delivers a state-of-the-art architecture that has a meaningful technological lead beyond conventional short-clip video generation. The same core capability could support a remarkably broad range of commercial opportunities, from robotics and physical simulation to gaming, live commerce, education, and real-time creative media.”
Visko was founded in 2025 by Qing (Will) Yin, a Stanford Ph.D. in Computational Mathematics and Mechanics who spent three years as a researcher at Apple. The company’s 16-person team draws from Apple, Google DeepMind, Meta, Amazon, and Tesla, and is advised by Michael I. Jordan of the University of California, Berkeley; Steve WaiChing Sun of Columbia University; and academic partner, Mengye Ren of New York University. Distribution is handled through Visko’s partner Reactor.
About Visko
Visko is an AI research company pioneering Live Models — a new class of world models that run rather than render. Where conventional AI video generates a clip and stops, Visko’s foundation model, Orbis, simulates a world and streams it live: physics-grounded, interactive, with persistent memory and no fixed length. The company’s thesis is that the next paradigm of AI is not a model you call, but a process that runs in step with the world itself. Founded by Stanford Ph.D. and former Apple researcher Qing (Will) Yin, Visko is headquartered in Sunnyvale, California, and has raised $10 million led by Llama Ventures. Learn more at visko.ai.
Silicon Valley technology company advances enterprise adoption through an integrated AI-powered ecosystem connecting payments, commerce, logistics and travel
PALO ALTO, Calif., Sept. 1, 2026 — PayToMe.co, a Silicon Valley AI and financial technology company, today announced the continued global expansion of its AI-powered commerce platform, connecting FinTech, commerce, logistics and travel through an integrated ecosystem serving consumers and enterprises in the United States and international markets.
PayToMe.co’s AI-enabled payment platform helps businesses simplify global transactions, automate financial workflows and connect commerce experiences.
Businesses and consumers operate in a world where money, commerce, goods and people move continuously, yet the technology supporting those activities remains fragmented across payments, financial operations, customer engagement, fulfillment, logistics and service. PayToMe.co connects that journey through technology designed to make complex transactions simpler, faster and more intelligent.
The company is accelerating enterprise adoption, strategic relationships and international reach while continuing to advance AI, automation, embedded FinTech and enterprise APIs.
Intelligence Behind the Network
PayToMe.co and its internal software development team have developed technology designed to intelligently orchestrate financial and commerce workflows across one connected environment.
Its platform combines AI, intelligent workflow automation, embedded payments, Text-to-Pay, digital invoicing, KYC/KYB, financial management, data intelligence and enterprise APIs to reduce manual processes across transactions, payments, customer engagement and workflow execution.
The PayToMe.co ecosystem connects with approximately 12,000 financial institutions and 7,000 applications through integrated financial technology networks. Its technology and service ecosystem includes AWS, Stripe, Plaid, Intuit QuickBooks, FedEx, UPS and DHL. PayToMe.co has received support from Startupbootcamp and Hatcher+, also participates in IBM Partner Plus and NVIDIA Inception.
PayToMe.co is designed to connect capabilities businesses already need and make them easier to access, automate and distribute. Through LuggageToShip.com, ShipAndStorage.com and ShipToBox.com, PayToMe.co extends its ecosystem across travel logistics, technology-enabled storage and domestic and international shipping.
One platform. One API. Global reach.
AI Connects Transactions to Their Destinations
Artificial intelligence is rapidly evolving from generating information toward executing real-world business processes. PayToMe.co applies AI as operating intelligence across its platform, helping software understand transactions, payments, destinations, customer requirements and available options while automating activities that traditionally require multiple companies, systems and manual decisions.
“AI provides the intelligence. FinTech moves the money. Commerce drives transactions. Logistics moves the goods. Travel moves the people. PayToMe.co connects the journey,” said Mike Ulker, CEO of PayToMe.co.
Built for a World That Never Stops Moving
Global business is becoming more digital, mobile and complex. Supply-chain volatility, inflationary pressure, cybersecurity risk, geopolitical uncertainty and climate-related disruption are increasing demand for flexible, connected infrastructure. At the same time, businesses face rising expectations for instant payments, automation, digital verification and seamless connections between online transactions and physical commerce.
PayToMe.co operates at this intersection, connecting financial technology, AI, commerce, logistics, storage and travel through an integrated ecosystem supporting services across up to 220 countries and territories.
Designed to work across existing business environments, PayToMe.co helps enterprises connect customer experiences, automate workflows and extend capabilities without independently building every financial, commerce or logistics function.
PayToMe.co combines its proprietary technology, internal software development capabilities and established commercial platforms to connect financial technology with real-world commerce—creating scalable infrastructure that helps businesses and consumers operate across domestic and global markets.
Businesses seeking to integrate payments, intelligent automation, commerce or logistics capabilities—and organizations interested in strategic partnerships—can learn more at www.paytome.co or contact [email protected]
About PayToMe.co
PayToMe.co is a Silicon Valley AI and financial technology company providing an integrated platform connecting payments, financial operations, intelligent automation and global commerce. Its ecosystem includes LuggageToShip.com, ShipToBox.com and ShipAndStorage.com, extending the company’s reach across commerce, logistics, storage and travel while supporting customers across the United States and international markets.
SHOP. SHIP. STORE. TRAVEL. PAY. Powered by PayToMe.co.
LAKE FOREST, Calif., Sept. 1, 2026 — Sonorous Neurovascular, a medical device company focused on cerebral venous diseases and neurovascular interventions, today announced that it has enrolled its first patient at a Toronto hospital in B-SILENT (NCT07070089), an international clinical study evaluating an investigational cerebral venous stent for patients with debilitating pulsatile tinnitus associated with symptomatic cerebral venous sinus stenosis. The clinical evaluation is being led by Dr. Vitor Mendes Pereira, neurosurgeon and Director of Endovascular Research and Innovation at St. Michael’s Hospital in Toronto, Canada.
The St. Michael’s Hospital neurovascular team, with Dr. Vitor Mendes Pereira (third from left), following the site’s first B-SILENT study enrollment in Toronto, Canada.
The B-SILENT study is evaluating the investigational use of BosSTENT™, Sonorous’ braided, self-expanding cerebral venous stent, for the treatment of debilitating pulsatile tinnitus caused by symptomatic cerebral venous sinus stenosis. The study is designed to generate essential safety and performance data to support a future CE Mark submission.
St. Michael’s and The Ottawa Hospital are Canadian sites in B-SILENT, extending the study’s international enrollment beyond France, where four clinical sites are participating. The collaboration across French and Canadian centers reflects growing clinical interest in generating rigorous evidence for the treatment of pulsatile tinnitus associated with cerebral venous sinus stenosis.
At St. Michael’s, B-SILENT is coordinated through the RADIS Lab, with Eileen Liu and Alphonse Potvin providing clinical support for the study.
“The expansion of B-SILENT into Canada is an important step for the study and for patients living with debilitating pulsatile tinnitus,” said Joel Harris, CEO of Sonorous Neurovascular. “We are grateful to Dr. Pereira and the St. Michael’s team, Dr. Fahed and the team at The Ottawa Hospital, and our colleagues across France for their commitment to advancing this research. Their collaboration is essential to building the clinical evidence needed to evaluate this investigational therapy.”
“Pulsatile tinnitus can be extremely debilitating, yet patients often spend years searching for an explanation and an effective treatment. In appropriately selected patients, venous sinus stenosis can be an important underlying cause. B-SILENT gives us the opportunity to rigorously evaluate a technology specifically designed for the cerebral venous system and, ultimately, to build the evidence needed to improve how we treat these patients,” said Dr. Pereira.
Sonorous Neurovascular continues to progress its clinical programs across both U.S. and international regulatory pathways, building on the company’s FDA Breakthrough Device Designation for BosSTENT™ and 510(k) clearance for BosCATH™. These achievements support Sonorous’ mission of improving the lives of patients affected by pulsatile tinnitus and other venous outflow disorders through minimally invasive, purpose-built therapies.
About Sonorous Neurovascular
Sonorous Neurovascular is a clinical-stage medical device company headquartered in Lake Forest, California, dedicated to developing transformative technologies for the treatment of cerebral venous diseases. The company’s innovative portfolio, including the BosSTENT™ (recently granted FDA Breakthrough Device Designation) and BosCATH™, aims to provide safe, effective, and purpose-built solutions that improve patient outcomes. Sonorous is actively advancing international clinical research, including the B-SILENT study (NCT07070089) evaluating the investigational use of BosSTENT™ for debilitating pulsatile tinnitus at sites in France and Canada to support CE Mark submission. For more information, visit www.sonorousnv.com.
Contact: James D. Nonato, Vice President Sonorous Neurovascular Email: [email protected] Phone: +1 (888) 830 1445
DataAgent autonomously fixes production faults inside an organization’s own infrastructure so incidents close faster and engineering teams stop paying to ship their data to an outside vendor
TEL AVIV, Israel, Sept. 1, 2026 — DataAgent, the developer of a remediation-first Digital Immune System (DIS) for modern applications, today announced that the company has emerged from stealth with the launch of its platform and the closing of a $10 million pre-seed funding round.
DataAgent’s pre-seed funding round was led by MizMaa Ventures and Alicorn Venture Partners. DataAgent intends to use the proceeds from this funding to bring its remediation-first platform to market and accelerate customer adoption in North America.
DataAgent’s founders: CTO Nati Shalom (left) and CEO Ishay Yaari (right)
DataAgent is led by the company’s two Co-Founders Ishay Yaari (CEO) and Nati Shalom (CTO), who worked together at Cloudify, a cloud orchestration company acquired by Dell in 2023. The company currently has a team of 15 and is actively recruiting additional go-to-market staff in the United States and Israel.
DataAgent’s remediation-first platform acts as an AI-native autonomous SRE (site reliability engineer) for Kubernetes and connected infrastructure. The platform operates directly within cloud-native control planes and integrates with existing observability systems as a lightweight overlay rather than a replacement.
The platform deploys agents to capture high-fidelity signals at the source and acts autonomously to remediate issues the moment a fault occurs, which eliminates the need for expensive external data transfers. By forwarding only relevant data for deeper inspection when a fault requires it, the DataAgent platform enables teams to drastically lower their observability bill without downtime or the risk of a full migration.
“In DataAgent, observability is just one feature – the real product is a self-healing infrastructure,” said Ishay Yaari, Co-Founder and CEO of DataAgent. “We pair a production remediation engine that fixes failures after they happen with a pre-production engine that blocks them before code ever ships. And they are not separate products: prevention and remediation are fused into one continuous lifecycle, so the system gets smarter with every failure it stops and every incident it resolves.”
“Applying rapidly evolving AI technology to major pain points with transformational results is the holy grail”, said Catherine Leun, Co-Founder and Partner at MizMaa Ventures. “DataAgent is doing exactly that by moving observability beyond insight and toward action.”
“DataAgent is attacking one of the most expensive and persistent problems in modern software infrastructure: systems that can tell engineers something is broken, but cannot safely fix it,” said Alexander Assim, Managing Partner of Alicorn Venture Partners. “What attracted us to DataAgent is the company’s ability to combine autonomous remediation with a deployment model that keeps customer infrastructure and telemetry under the customer’s control.”
Reversing the Order of Operations
Conventional observability platforms detect a fault and route it to an engineer, who then investigates and applies a fix. This model requires a second, paid copy of a customer’s telemetry – the logs and metrics a system produces about itself – to be shipped to a vendor’s cloud. This process grows more expensive as the system it watches grows. Observability spending now averages 17% of total compute infrastructure spending, according to Grafana Labs’ 2025 Observability Survey.
DataAgent reverses that order. The platform reads live system state, topology and configuration drift where the data already sits, identifies the cause of an incident and applies a verified fix. A deeper root-cause analysis is run offline after the service is restored. By restoring service first, rather than waiting on deep diagnostics, DataAgent dramatically shortens mean-time-to-resolution (MTTR). Telemetry never leaves the customer’s environment because the platform runs directly inside their own cluster and integrates alongside existing observability tools rather than replacing them.
“Traditional observability is hitting a wall of complexity and cost,” according to the research analyst firm Gartner. “Agentic AI breaks down silos and accelerates root cause analysis by moving from explanation to action. This collaborative approach enables self-healing and self-optimizing systems, bridging the gap from data to insight to action.”
Platform Capabilities
Four elements of the platform’s design enable support for autonomous remediation:
Remediation-first – the platform autonomously resolves incidents in real-time and restores uptime using safe, guardrail-controlled actions the user defines rather than relying on traditional approaches to root-cause analysis that require expensive data ingestion transfers.
360-degree architectural context – the platform builds a working model of the customer’s topology, environment, code and configuration rather than acting on isolated logs and traces. A fix applied to a misread system state carries real risk, so precision determines what the platform can safely do on its own.
Continuous reinforcement learning – during onboarding, the platform runs a discovery phase that shows a customer which classes of failure it can already remediate and sets out a timeline for closing the remaining gaps. The platform adapts to new failure modes over time and acts autonomously on a class of fault only once it has been proven correct on that class, while other cases are routed for human intervention, deployable through the user’s existing change-management process or a single CLI command.
An open-source agent – the platform’s agent is open source and can be deployed and run standalone at no cost with a paid SaaS tier for fleet management and orchestration. This approach addresses enterprise resistance to running closed software inside production environments.
“The industry has spent 15 years building better ways to watch production and charging more for it every year. Legacy tools have become data-heavy and reactive, while recent attempts to bolt AI copilots onto this broken model have not changed the outcome,” explained Nati Shalom, Co-Founder and CTO of DataAgent. “We have built DataAgent the other way around. Our platform and agents act where the data already sits, restore health first and earn autonomy one fault class at a time. Autonomy is not an add-on feature for observability; it is a fundamental architectural shift that slashes costs as a direct result.”
Financial Impact
The design of the DataAgent platform includes two important financial benefits for customers:
Adoption without replacement – customers can run the DataAgent platform above their existing monitoring stack, where it resolves routine faults locally and forwards data for deeper inspection only when a fault requires it. Teams see results without the downtime and the risk of a full migration, while drastically lowering their observability bill.
Analyzing telemetry locally – instead of ingesting and indexing terabytes of redundant logs, DataAgent’s root cause analysis engine focuses deep inspection on the small fraction of code paths that dictate stability. This dramatically scales down expensive log-indexing pipelines, yielding a far lower cost structure than legacy tools.
“In ten years, no one has ever heard an engineering leader say their organization’s observability costs went down and that is no accident,” said Yaari. “When a vendor’s revenue is your data ingest, it cannot cut your bill without cutting its own. DataAgent can run alongside your existing tools, while filtering out the noise and rerouting data only when an incident demands it. There is no need for an expensive second copy of your data and everything pulled live from the source so customers can cut up to 90% of their observability spend.
About DataAgent
DataAgent is building a Digital Immune System for modern applications: a private, enterprise-grade, remediation-first platform designed to replace legacy observability tools. Founded in January 2026 and led by CEO Ishay Yaari and CTO Nati Shalom, the company prioritizes real-time autonomous remediation, including restarting, scaling and rolling back workloads, over conventional root-cause analysis. By processing in-cluster and working from a focused set of core metrics, DataAgent removes the need for large data ingestion pipelines. The company has operating infrastructure in the United States and Israel and closed a $10 million pre-seed round in 2026 led by MizMaa Ventures and Alicorn Venture Partners. For more information, please visit www.data-agent.co.
Berkeley-rooted company unveils algorithmic neuroscience platform for political polling, messaging, fundraising and voter persuasion
BERKELEY, Calif., Sept. 1, 2026 — Amygdala Corp., www.amygdala.com, whose technology successfully predicted a key upset in recent Wisconsin primaries, is bringing a disruptive new technology platform to politics: Algorithmic Neuroscience.
Built on technology developed by neuroscience and engineering teams with Berkeley roots, Amygdala is pioneering NeuroPolitics — the application of neuroscience to political strategy.
“We had tremendous success applying neuromarketing to some of America’s leading brands,” said Dr. A.K. Pradeep, Amygdala chairman and co-founder. “Now we are taking those neuroscience insights from brand and market competition and applying them to something even more consequential: helping candidates win elections.”
Amygdala is built on cutting-edge science and engineering. Dr. A. K. Pradeep’s latest foundational work on neural state reduction becoming reportable thought has been accepted for publication in the peer-reviewed Frontiers of Computational Neuroscience, a multidisciplinary journal that focuses on the theoretical modeling of brain function.
The company draws on a team with decades of neuromarketing experience with major global brands to model how voters respond at a non-conscious level. Its technology focuses on two powerful neural systems: the limbic mechanisms underlying threat and emotional response, and the brain mechanisms that create Desire.
Pradeep previously founded NeuroFocus, which was acquired by Nielsen (NiQ) and became a global leader in neuromarketing. Amygdala applies these principles across political messaging, polling, voter-level issue framing and fundraising. The platform is already being deployed in congressional, gubernatorial and state legislative races across the Midwest.
Its synthetic polling moves beyond conventional digital personas. Amygdala creates neuroscience-grounded Dynamic Digital Twins using neurographic profiles of real voters. The approach combines neural-state modeling to deliver polling that is faster, less expensive and designed to capture the forces underlying voter choice.
“NeuroPolitics models what voters actually feel beneath conscious reporting — not simply what they say,” said Devin Pracar, Amygdala co-founder and VP of Product.
Amygdala continues expanding its leadership network. The company recently added Caroline Winnett, executive director of SkyDeck, the startup ecosystem of U.C. Berkeley to its advisory board. She joins the board that includes veteran Democratic strategist Joe Trippi, and political strategist Alex Shashlo.
“We are assembling extraordinary expertise across politics, neuroscience, technology and entrepreneurship,” said Dr. Robert Tatterson, CEO of Amygdala. “The sky is the limit for Amygdala as a company, and the field of NeuroPolitics.”
About Amygdala
Amygdala is a political technology company at the intersection of neuroscience, artificial intelligence and political strategy. Its NeuroPolitics platform uses Algorithmic Neuroscience to understand non-conscious voter response, generate advanced polling insights, optimize political messaging and help campaigns turn voter understanding into electoral advantage.
Contact: Mike Smith Chief Political Officer Amygdala [email protected] 703-623-3834
